Therapeutic Vaccines

World Market Report

MCP15190

EXECUTIVE ENGAGEMENTS

POOL

563
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

113
Interactions with Platform & by Email

PARTICIPANTS

23
Unique # Participated

VALIDATIONS

9
Responses Validated*

COMPANIES

13
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

123

PAGES

182

EDITION

8

PRICE

USD 4950

CODE

MCP15190


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Therapeutic Vaccines Market to Reach $71.2 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Therapeutic Vaccines estimated at US$24.6 Billion in the year 2020, is projected to reach a revised size of US$71.2 Billion by 2027, growing at a CAGR of 16.4% over the analysis period 2020-2027. Autoimmune Disease Vaccines, one of the segments analyzed in the report, is projected to record a 17% CAGR and reach US$37.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Neurological Disease Vaccines segment is readjusted to a revised 17.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.8 Billion, While China is Forecast to Grow at 21.8% CAGR
The Therapeutic Vaccines market in the U.S. is estimated at US$6.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.7 Billion by the year 2027 trailing a CAGR of 21.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 14.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$10.5 Billion by the year 2027.



Infectious Disease Vaccines Segment to Record 15.6% CAGR
In the global Infectious Disease Vaccines segment, USA, Canada, Japan, China and Europe will drive the 15.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.8 Billion in the year 2020 will reach a projected size of US$7.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 17.1% CAGR through the analysis period.

SELECT PLAYERS

Agenus, Inc.; Bavarian Nordic A/S; CEL-SCI Corporation; Dendreon Corporation; GlaxoSmithKline PLC; Novartis International AG; Oncothyreon, Inc.; TVAX Biomedical Inc.; Vical, Inc.

SEGMENTS

» Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines, Addiction Vaccines)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Therapeutic Vaccines – Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for 13 Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Therapeutic Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Therapeutic Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Therapeutic Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Therapeutic Vaccines Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CANADA
Canada Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
JAPAN
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CHINA
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
EUROPE
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Therapeutic Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Therapeutic Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Therapeutic Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
GERMANY
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ITALY
Italy Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SPAIN
Spain Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
RUSSIA
Russia Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Therapeutic Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Therapeutic Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
AUSTRALIA
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
INDIA
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
LATIN AMERICA
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Therapeutic Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Therapeutic Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Therapeutic Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
BRAZIL
Brazil Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
MEXICO
Mexico Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
MIDDLE EAST
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Therapeutic Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Therapeutic Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Therapeutic Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ISRAEL
Israel Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
AFRICA
Therapeutic Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Therapeutic Vaccines by Segment - Therapeutic Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Therapeutic Vaccines by Segment - Therapeutic Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com